Search the Newsreel

Element Pointe Advisors LLC Invests $836,000 in Thermo Fisher Scientific Inc. $TMO

Element Pointe Advisors LLC acquired a new stake of 1,668 shares, valued at $836,000, in Thermo Fisher Scientific Inc. during the second quarter. Other institutional investors have also increased their holdings, with BlackRock Inc. buying a significant new position worth over $15 billion. The …

First National Bank of Omaha Buys New Position in Thermo Fisher Scientific Inc. $TMO

First National Bank of Omaha has acquired a new position in Thermo Fisher Scientific Inc. (NYSE:TMO), purchasing 27,553 shares valued at approximately $13.895 million. This move is part of broader institutional interest, with several other firms also adjusting their stakes in the medical research …

Deutsche Bank AG Makes New Investment in US Foods Holding Corp. $USFD

Kronox Lab Sciences promoters sell 64.26% stake to Indo Borax

Best Growth Stocks to Buy for August 20th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 20: Schneider National, Inc. SNDR: This provider of truckload, intermodal, and logistics services a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current …

3,366 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by BOK Financial Private Wealth Inc.

BOK Financial Private Wealth Inc. acquired 3,366 shares of Thermo Fisher Scientific Inc. (NYSE:TMO) for approximately $1.69 million in the second quarter. Institutional investors and hedge funds own 89.23% of the company, which recently reported strong quarterly earnings with $6.03 EPS and $11.99 billion …

Ascentage Pharma H1 Loss Widens, Revenue Rises

2,463 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by Alpine Woods Capital Investors LLC

Alpine Woods Capital Investors LLC recently purchased 2,463 shares of Thermo Fisher Scientific (NYSE:TMO) valued at approximately $1.24 million in the second quarter. Other institutional investors have also adjusted their holdings in the company, with institutional investors and hedge funds collectively owning 89.23% of …

Does Gilead (GILD) Pairing With Nucleai Reveal a Deeper Shift in Its Oncology Strategy?

In August 2026, Nucleai announced an ongoing translational research collaboration with Gilead Sciences, using AI-powered tissue analytics to support Gilead's global antibody-drug conjugate clinical development programs across multiple oncology indications. The partnership highlights how integrating AI-native computational pathology with clinical outcomes may help standardize …

Charles Schwab (SCHW) Stock Fair Value Rises After Strong Q2 And Analyst Target Increases

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Charles Schwab's updated model now points to a Fair Value price target of US$125.00, compared with the previous US$116.16 figure. Analysts link this …

Edwards Lifesciences (EW) Stock Could Be 1% Above Fair Value On Cash Flow And Earnings

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Edwards Lifesciences stock has delivered a 21.6% gain over the past three years, yet the valuation checks paint a less generous picture. The intrinsic value estimate from …

Schneider Electric stock holds near one-year high as AI partnership adds momentum

Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Solid Biosciences Inc. (NASDAQ:SLDB) has received a "Moderate Buy" consensus rating from eleven brokerages, with an average 12-month price target of $17.11. The company's stock opened at $9.74, and institutional investors own a substantial 81.46% of its shares. Solid Biosciences recently reported a quarterly …

Science Group Adds to Treasury Stock with Targeted Share Buyback

Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Rating of "Moderate Buy" by Analysts

Castle Biosciences, Inc. (NASDAQ:CSTL) has received a "Moderate Buy" rating from analysts, with an average 12-month price target of $42.00, significantly above its recent opening price. The company exceeded quarterly revenue and adjusted EPS expectations but remains unprofitable with a negative net margin. Institutional …

Original-Research: GESCO SE (von GSC Research GmbH): Kaufen

Predictive Discovery (ASX:PDI) Stock Advances on Bankan Gold Project Development

Genesco (GCO) Projected to Release Quarterly Earnings on Thursday

Genesco (GCO) is expected to report its Q2 2027 earnings before market open on Thursday, August 27th. Analysts forecast a loss of $1.34 per share on revenue of $528.4 million. The company's full-year EPS guidance is set between $2.00 and $2.40, with recent institutional …

Moolec (MLEC) Q2 2025 Scorecard: EPS Comes in Above Forecast in the Latest Reading; Trading Response: Shares Move 2.92% Down in the Current Update - Profitability Analysis

Anheuser-Busch InBev stock holds in the high $70s as Q2 2026 earnings reinforce growth

Anheuser-Busch InBev (BUD) stock is trading in the high $70s, closing at $77.46 on August 18, 2026, supported by strong Q2 2026 earnings. The company reported $16.66 billion in revenue and $3.75 billion in earnings for the quarter, demonstrating solid financial performance. With a …

Solara Active Pharma Sciences Ltd. Share Price Rises 8.49%

FDA Broadens ‘Indications for Use’ for Sight Sciences’ TearCare System

Sight Sciences, Inc. announced that the FDA has expanded the indications for use for its TearCare System, making it the first and only treatment for meibomian gland dysfunction (MGD) indicated to improve meibomian gland function in adult patients with evaporative dry eye disease. This …

WillScot (WSC) Results at a Glance: EPS Clears the Reported Estimate in the Latest Session; Post-Report: Shares Close 1.05% Lower on the Day - Financial Summary

Scholar Rock Holding (SRRK) After Apitegromab Progress Is The Stock Already Fully Valued

WESCO EVP Akash Khurana sells $1.25m in company stock By Investing.com

WESCO Executive Vice President Akash Khurana sold company stock valued at approximately $1.25 million on August 17, 2026, across various transactions at weighted average prices between $366.1 and $368.27 per share. Despite WCC shares delivering a 63% return over the past year, InvestingPro analysis …

IDEAYA (IDYA) Results Check: The EPS Result Is Below Expectation in Latest Trading; Shares Close 2.48% Higher for the Current Session - Earnings Miss Alert

ETFs Investing in Shanghai Junshi Biosciences Co., Ltd. Class H Stocks

Twist (TWST) Results at a Glance: EPS Misses Its Estimate in the Available Record; Investor Response: The Stock Gains 22.64% in the Latest Reading - Post-Earnings Reaction

BlueScope Steel (ASX:BSL): Why Could This Value Stock Matter Now?

Twist (TWST) Results at a Glance: EPS Misses Its Estimate in the Available Record; Investor Response: The Stock Gains 22.64% in the Latest Reading - Net Profit Margin

Fortescue (ASX:FMG) share price in focus on $2.9 billion net profit in FY26 result

Fortescue (ASX:FMG) FY26 Profit Rises 3% as Record Iron Ore Shipments Support A$1.08 Dividend

Fortescue (ASX:FMG) Reaches Record Shipments But Iron Bridge Impairment Impacts FY26 Profit

Transcat (TRNS) Results Check: The Bottom-Line Figure Beats Its Comparison in the Latest Reading; Closing Reaction: Shares Rise 0.88% at the Close - Earnings Seasonality

Does VISN’s Profit Surge And US$5 Special Payout Change The Bull Case For Vistance Networks (VISN)?

Vistance Networks (VISN) reported a significant surge in net income to US$295.2 million in Q2 2026, despite a slight decrease in sales. The company also declared a US$5.00 per share special cash distribution, prompting questions about the sustainability of its profitability and its capital …

Fortescue shares swing as profit and dividend miss expectations